Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CBIO · NASDAQ · Pharmaceutical Preparations
$13.00+0.09 (+0.70%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Crescent Biopharma (CBIO) · oqro.io/stocks/CBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
BALYASNY ASSET MANAGEMENT L.P. cut its CBIO stake below 5% (4.3%)SourceInsider trade · Traded Sep 18, 2026 · Filed Sep 18, 2026
CEO sold ~$131K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
CEO sold ~$29K of CBIO shares in the open marketSourceInsider trade · Traded Sep 18, 2026 · Filed Sep 18, 2026
Officer sold ~$64K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
CFO sold ~$10K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
Officer sold ~$13K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
Officer sold ~$12K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
Officer sold ~$11K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
Officer sold ~$11K of CBIO shares in the open marketSourceInsider trade · Traded Sep 16, 2026 · Filed Sep 18, 2026
Officer sold ~$4.3K of CBIO shares in the open marketSourceInsider trade · Traded Jul 16, 2026 · Filed Jul 20, 2026
Director purchased ~$12.4M of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
CEO sold ~$761K of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
Officer sold ~$370K of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
CFO sold ~$20K of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
Officer sold ~$23K of CBIO shares in the open marketSourceInsider trade · Traded Dec 4, 2025 · Filed Dec 8, 2025
Director purchased ~$18.2M of CBIO shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP no longer reported CBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in CBIO for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in CBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed a new position in CBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a new position in CBIO for Q2 2025SourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
Officer sold ~$22K of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
Officer sold ~$22K of CBIO shares in the open marketSourceInsider trade · Traded Jun 22, 2026 · Filed Jun 23, 2026
Officer sold ~$8.4K of CBIO shares in the open marketSource